Apolipoprotein E Codetermines Tissue Tropism of Hepatitis C Virus and Is Crucial for Viral Cell-to-Cell Transmission by Contributing to a Postenvelopment Step of Assembly

ABSTRACT Hepatitis C virus (HCV) predominantly infects human hepatocytes, although extrahepatic virus reservoirs are being discussed. Infection of cells is initiated via cell-free and direct cell-to-cell transmission routes. Cell type-specific determinants of HCV entry and RNA replication have been reported. Moreover, several host factors required for synthesis and secretion of lipoproteins from liver cells, in part expressed in tissue-specific fashion, have been implicated in HCV assembly. However, the minimal cell type-specific requirements for HCV assembly have remained elusive. Here we report that production of HCV trans-complemented particles (HCVTCP) from nonliver cells depends on ectopic expression of apolipoprotein E (ApoE). For efficient virus production by full-length HCV genomes, microRNA 122 (miR-122)-mediated enhancement of RNA replication is additionally required. Typical properties of cell culture-grown HCV (HCVcc) particles from ApoE-expressing nonliver cells are comparable to those of virions derived from human hepatoma cells, although specific infectivity of virions is modestly reduced. Thus, apolipoprotein B (ApoB), microsomal triglyceride transfer protein (MTTP), and apolipoprotein C1 (ApoC1), previously implicated in HCV assembly, are dispensable for production of infectious HCV. In the absence of ApoE, release of core protein from infected cells is reduced, and production of extracellular as well as intracellular infectivity is ablated. Since envelopment of capsids was not impaired, we conclude that ApoE acts after capsid envelopment but prior to secretion of infectious HCV. Remarkably, the lack of ApoE also abrogated direct HCV cell-to-cell transmission. These findings highlight ApoE as a host factor codetermining HCV tissue tropism due to its involvement in a late assembly step and viral cell-to-cell transmission.

[1]  Raymond T Chung,et al.  Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin , 2008, Hepatology.

[2]  F. Zoulim,et al.  Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells , 2013, Journal of Virology.

[3]  S. Pfeffer,et al.  Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells , 2012, Journal of Virology.

[4]  Robert J. Linhardt,et al.  Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate* , 2003, Journal of Biological Chemistry.

[5]  A. Burt,et al.  Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients , 2006, Journal of Virology.

[6]  T. Pietschmann,et al.  Entry and replication of recombinant hepatitis C viruses in cell culture. , 2013, Methods.

[7]  Sangeeta N. Bhatia,et al.  Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system , 2010, Nature Biotechnology.

[8]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[9]  M. Imamura,et al.  Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor , 2011, Nature Medicine.

[10]  M. Hiet,et al.  Mouse hepatic cells support assembly of infectious hepatitis C virus particles. , 2011, Gastroenterology.

[11]  Thomas Lengauer,et al.  Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. , 2011, Cell host & microbe.

[12]  L. Seeff,et al.  Natural history of chronic hepatitis C , 2002, Hepatology.

[13]  J. Dubuisson,et al.  Role of low‐density lipoprotein receptor in the hepatitis C virus life cycle , 2012, Hepatology.

[14]  H. Tillmann,et al.  Hepatitis C virus infection and the brain , 2004, Metabolic Brain Disease.

[15]  C. Rice,et al.  CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells , 2009, The Journal of general virology.

[16]  D. Lavanchy,et al.  Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  S. Emerson,et al.  Apolipoprotein C1 Association with Hepatitis C Virus , 2008, Journal of Virology.

[18]  Benjamin Israelow,et al.  HepG2 Cells Expressing MicroRNA miR-122 Support the Entire Hepatitis C Virus Life Cycle , 2011, Journal of Virology.

[19]  R. Bartenschlager,et al.  Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses , 2006, Journal of Virology.

[20]  C. Rice,et al.  Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Rowe,et al.  Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. , 2001, Virology.

[22]  J. McLauchlan,et al.  Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. , 2000, The Journal of general virology.

[23]  D. Lavillette,et al.  The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus , 2008, Journal of Virology.

[24]  Sangeeta N Bhatia,et al.  Modeling hepatitis C virus infection using human induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[25]  F. Penin,et al.  Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions , 2007, PLoS pathogens.

[26]  F. Chisari,et al.  Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion , 2007, Journal of Virology.

[27]  M. Gale,et al.  Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. , 2009, Virology.

[28]  D. Trono,et al.  Lentiviral Vectors Interfering with Virus-Induced CD4 Down-Modulation Potently Block Human Immunodeficiency Virus Type 1 Replication in Primary Lymphocytes , 2004, Journal of Virology.

[29]  Charles M. Rice,et al.  Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus , 2012, Proceedings of the National Academy of Sciences.

[30]  L. Kaderali,et al.  Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver‐derived cells , 2014, Hepatology.

[31]  Xianfang Wu,et al.  Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate , 2012, Journal of Virology.

[32]  R. Thomssen,et al.  Association of hepatitis C virus in human sera with beta-lipoprotein. , 1992, Medical microbiology and immunology.

[33]  M. Mizokami,et al.  Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. , 2003, Gastroenterology.

[34]  G. Thomson A direct deduction of the constant process used in the method of right and wrong cases. , 1919 .

[35]  M. Harada,et al.  High‐density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus , 2003, Journal of medical virology.

[36]  R. Bartenschlager,et al.  The lipid droplet is an important organelle for hepatitis C virus production , 2007, Nature Cell Biology.

[37]  Jieyun Jiang,et al.  Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture , 2007, Journal of Virology.

[38]  L. Kaderali,et al.  Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment , 2013, PLoS pathogens.

[39]  G. Kärber,et al.  Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche , 1931, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.

[40]  J. McKeating,et al.  Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. , 2011, Journal of hepatology.

[41]  N. Heaton,et al.  Molecular Determinants and Dynamics of Hepatitis C Virus Secretion , 2012, PLoS pathogens.

[42]  J. McKeating,et al.  Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies , 2007, Hepatology.

[43]  L. Kaderali,et al.  MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles , 2012, PLoS pathogens.

[44]  Céline Hernandez,et al.  Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. , 2010, Gastroenterology.

[45]  R. Thomssen,et al.  Association of hepatitis C virus in human sera with β-lipoprotein , 2004, Medical Microbiology and Immunology.

[46]  Charles M. Rice,et al.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells , 2009, Nature.

[47]  Jinhong Chang,et al.  Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells , 2008, Journal of Virology.

[48]  C. Spearman,et al.  The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae , 1908 .

[49]  A. Shavinskaya,et al.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  B. Lindenbach Virion assembly and release. , 2013, Current topics in microbiology and immunology.

[51]  Philip Roelandt,et al.  Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. , 2012, Journal of hepatology.

[52]  R. Bartenschlager,et al.  Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles , 2008, Journal of Virology.

[53]  Liang-Tzung Lin,et al.  Replication of Subgenomic Hepatitis C Virus Replicons in Mouse Fibroblasts Is Facilitated by Deletion of Interferon Regulatory Factor 3 and Expression of Liver-Specific MicroRNA 122 , 2010, Journal of Virology.

[54]  A. Moorman,et al.  The osmolarity of the electroporation medium affects the transient expression of genes. , 1990, Nucleic acids research.

[55]  S. Lemon,et al.  Liver injury and disease pathogenesis in chronic hepatitis C. , 2013, Current topics in microbiology and immunology.

[56]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.

[57]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[58]  T. Pietschmann,et al.  Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles* , 2009, The Journal of Biological Chemistry.

[59]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[60]  V. Agnello,et al.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  L. Kaderali,et al.  Isolate‐dependent use of claudins for cell entry by hepatitis C virus , 2014, Hepatology.

[62]  M. Hiet,et al.  Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome* , 2010, The Journal of Biological Chemistry.

[63]  A. Zignego,et al.  Hepatitis C virus lymphotropism: lessons from a decade of studies. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[64]  A. Thiele,et al.  Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins , 1993, Medical Microbiology and Immunology.

[65]  T. Baumert,et al.  Hepatitis C virus entry. , 2013, Current topics in microbiology and immunology.

[66]  B. Lindenbach,et al.  Trafficking of Hepatitis C Virus Core Protein during Virus Particle Assembly , 2011, PLoS pathogens.

[67]  R. De Francesco,et al.  Hepatitis C virus-specific directly acting antiviral drugs. , 2013, Current topics in microbiology and immunology.

[68]  G. Duverlie,et al.  Cell culture systems for the hepatitis C virus. , 2007, World journal of gastroenterology.

[69]  C. Englert,et al.  Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. , 1996, Virology.

[70]  David M. Gilbert,et al.  Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation , 2012, PLoS pathogens.

[71]  William J. Rice,et al.  Ultrastructural analysis of hepatitis C virus particles , 2013, Proceedings of the National Academy of Sciences.

[72]  S. Uprichard,et al.  Identification of transferrin receptor 1 as a hepatitis C virus entry factor , 2013, Proceedings of the National Academy of Sciences.

[73]  Xijun Song,et al.  Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C Virus , 2007, Journal of Virology.

[74]  M. Gale,et al.  Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins , 2007, Proceedings of the National Academy of Sciences.

[75]  M. Manns,et al.  Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles , 2011, Journal of Virology.

[76]  Olivier Poch,et al.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy , 2011, Nature Medicine.